Intensive Care Medicine

, Volume 11, Issue 6, pp 300–303

The haemostatic effects of hydroxyethyl starch (HES) used as a volume expander

Authors

  • E. Macintyre
    • Department of HaematologyMiddlesex Hospital
  • I. J. Mackie
    • Department of HaematologyMiddlesex Hospital
  • D. Ho
    • Department of HaematologyMiddlesex Hospital
  • J. Tinker
    • Department of Intensive Care MedicineMiddlesex Hospital
  • C. Bullen
    • Department of Intensive Care MedicineMiddlesex Hospital
  • S. J. Machin
    • Department of HaematologyMiddlesex Hospital
Original Articles

DOI: 10.1007/BF00273540

Cite this article as:
Macintyre, E., Mackie, I.J., Ho, D. et al. Intensive Care Med (1985) 11: 300. doi:10.1007/BF00273540

Abstract

Hydroxyethyl starch (HES 450.000/0.7; Hespan 6.0 g/100 ml) was compared with standard crystalloid solutions in postoperative volume replacement in 20 patients undergoing routine orthopaedic surgery. The HES group showed no clinical evidence of haemorrhage and no laboratory evidence of significant haemostatic defects as assessed by standard coagulation tests, platelet aggregation and fibrinogen concentrations. There was a slight shortening in the thrombin time and a smaller increase in postoperative FVIII RAg and FVIII RCof levels in the HES group. HES is a safe and effective volume expander for postoperative use.

Key words

Hydroxyethyl starch (HES)Factor VIII complexPlatelets
Download to read the full article text

Copyright information

© Springer-Verlag 1985